APA (7th ed.) Citation

CA, B., S, G., LN, C., M, M., LJ, D., A, T., . . . CGR, P. (2024). The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy. American journal of physiology. Cell physiology, 326(4), C1011. https://doi.org/10.1152/ajpcell.00638.2023

Chicago Style (17th ed.) Citation

CA, Bellissimo, et al. "The Slow-release Adiponectin Analog ALY688-SR Modifies Early-stage Disease Development in the D2.mdx Mouse Model of Duchenne Muscular Dystrophy." American Journal of Physiology. Cell Physiology 326, no. 4 (2024): C1011. https://doi.org/10.1152/ajpcell.00638.2023.

MLA (9th ed.) Citation

CA, Bellissimo, et al. "The Slow-release Adiponectin Analog ALY688-SR Modifies Early-stage Disease Development in the D2.mdx Mouse Model of Duchenne Muscular Dystrophy." American Journal of Physiology. Cell Physiology, vol. 326, no. 4, 2024, p. C1011, https://doi.org/10.1152/ajpcell.00638.2023.